| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA1506197 |
| P698 | PubMed publication ID | 26488693 |
| P50 | author | Richard Scolyer | Q28868730 |
| Janette L Vardy | Q47356845 | ||
| Haryana Dhillon | Q50695078 | ||
| Pablo Fernandez-Peñas | Q54286183 | ||
| P2093 | author name string | Anne Kricker | |
| Gary M Halliday | |||
| Diona L Damian | |||
| Andrew C Chen | |||
| Andrew J Martin | |||
| Bonita Choy | |||
| Catriona A McKenzie | |||
| Gayathri St George | |||
| Niranthari Chinniah | |||
| Robyn A Dalziell | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | niacinamide | Q192423 |
| phase III clinical trial | Q42824827 | ||
| P304 | page(s) | 1618-1626 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention | |
| P478 | volume | 373 |
| Q37093441 | 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis |
| Q49456531 | A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial |
| Q38786525 | A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin |
| Q52859211 | A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. |
| Q89672056 | Actinic Keratosis and Cutaneous Squamous Cell Carcinoma |
| Q49507357 | Arsenical keratosis secondary to Fowler solution. |
| Q99241201 | Beneficial effects of nicotinamide on hypertensive mice with impaired endothelial nitric oxide function |
| Q57035007 | Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials |
| Q47664315 | Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial |
| Q38884169 | Chemoprevention of Keratinocyte Carcinomas: An Updated Review |
| Q42497476 | Chemoprevention of basal cell carcinoma |
| Q50072700 | Chronic lymphocytic leukaemia and secondary skin malignancies |
| Q39311286 | Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review |
| Q90745209 | Cutaneous Photoprotection: A Review of the Current Status and Evolving Strategies |
| Q89744685 | Cutaneous squamous cell carcinoma in the organ transplant recipient |
| Q91048677 | De novo NAD+ biosynthetic impairment in acute kidney injury in humans |
| Q47572587 | Dermatological Complications After Solid Organ Transplantation |
| Q90512417 | Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide |
| Q40365857 | Does sunlight protect us from cancer? |
| Q64118468 | Effect of Nicotinamide Against |
| Q89908266 | Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential |
| Q33432308 | Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study |
| Q38892159 | Efficient Synthesis of Nicotinamide-1-¹⁵N for Ultrafast NMR Hyperpolarization Using Parahydrogen |
| Q47097802 | Emerging concepts and recent advances in basal cell carcinoma. |
| Q89181412 | Fanconi Anemia complementation group C protein in metabolic disorders |
| Q46160844 | Future cancer research priorities in the USA: a Lancet Oncology Commission |
| Q50055613 | Guidelines of care for the management of cutaneous squamous cell carcinoma |
| Q39037941 | Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank |
| Q98176758 | Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer |
| Q91441147 | Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs |
| Q38731383 | Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening |
| Q90315913 | Keratinocyte Carcinomas: Current Concepts and Future Research Priorities |
| Q38987077 | Management of Skin Cancer in the High-Risk Patient |
| Q39417544 | Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? |
| Q37522572 | More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients |
| Q28069862 | N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
| Q91046001 | NAD+ homeostasis in renal health and disease |
| Q90438582 | NAD+ in Brain Aging and Neurodegenerative Disorders |
| Q39218657 | NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability. |
| Q64055137 | Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide |
| Q48693743 | New and current preventive treatment options in actinic keratosis |
| Q40353635 | Niacin intake and risk of skin cancer in US women and men. |
| Q33800897 | Nicotinamide Administration Improves Remyelination after Stroke |
| Q47556627 | Nicotinamide Inhibits Ethanol-Induced Caspase-3 and PARP-1 Over-activation and Subsequent Neurodegeneration in the Developing Mouse Cerebellum |
| Q60310909 | Nicotinamide Promotes Cell Survival and Differentiation as Kinase Inhibitor in Human Pluripotent Stem Cells |
| Q39488135 | Nicotinamide Suppresses the DNA Damage Sensitivity of Saccharomyces cerevisiae Independently of Sirtuin Deacetylases |
| Q38842982 | Nicotinamide and phosphate homeostasis in chronic kidney disease |
| Q47807952 | Nicotinamide and skin cancer chemoprevention: The jury is still out. |
| Q48168815 | Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice? |
| Q39189282 | Nicotinamide for skin cancer chemoprevention |
| Q90355617 | Nicotinamide in the prevention of breast cancer recurrences? |
| Q33703205 | Nicotinamide metabolism regulates glioblastoma stem cell maintenance |
| Q39443978 | Nutrition, inflammation and cancer |
| Q55607113 | Oral Photoprotection: Effective Agents and Potential Candidates. |
| Q53126419 | Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial. |
| Q52626741 | Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression. |
| Q92860680 | Photoimmunology: how ultraviolet radiation affects the immune system |
| Q38857539 | Precancer Atlas to Drive Precision Prevention Trials. |
| Q90416488 | Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part II |
| Q30245112 | Primary and Secondary Chemoprevention of Malignant Melanoma |
| Q92322216 | Prise en charge thérapeutique des kératoses actiniques: Treatment of actinic keratoses |
| Q55185800 | Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas. |
| Q33799624 | Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer |
| Q88483814 | Red meat and processed meat intake and risk for cutaneous melanoma in white women and men: Two prospective cohort studies |
| Q48028621 | Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'. |
| Q46838064 | Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. |
| Q33752722 | Rice Bran Metabolome Contains Amino Acids, Vitamins & Cofactors, and Phytochemicals with Medicinal and Nutritional Properties |
| Q55266341 | Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network. |
| Q39337780 | Skin Cancers in Organ Transplant Recipients. |
| Q42484518 | Skin cancer: Nicotinamide reduces new skin cancer risk |
| Q49165535 | Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose |
| Q61808238 | The management of numerous carcinomatous sequelae of human papilloma virus in an allogeneic stem cell transplant patient with chronic graft versus host disease |
| Q91447644 | The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease |
| Q39145000 | The role of nicotinamide in acne treatment |
| Q91963526 | Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems |
| Q42360919 | Treatment of Actinic Purpura |
| Q47840579 | Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis |
| Q93048231 | Updates on Treatment Approaches for Cutaneous Field Cancerization |
| Q46811811 | Updates on the Management of Non-Melanoma Skin Cancer (NMSC). |
| Q36239629 | Use of nicotinamide in dermatology. |
| Q54690358 | [Cutaneous squamous cell carcinoma]. |
| Q54046888 | [New approaches for the prevention of actinic keratosis]. |
| Q51821884 | [The aged scalp : A dermato-oncological focus point]. |
| Q88382288 | [What is new in basal cell carcinoma?] |
Search more.